S&P 500

5.956,06

0,01%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
Canadá
TSX
Crescita Therapeutics Inc (CTX)
Crescita Therapeutics Inc (CTX) Notícias

CTX

Crescita Therapeutics (CTX)

Crescita Therapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:TSX:CTX

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
01/06/2023	06:00	PR Newswire (Canada)	Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe	TSX:CTX	Crescita Therapeutics Inc
21/01/2021	09:30	PR Newswire (US)	Crescita Announces Filing of New Medical Device License	TSX:CTX	Crescita Therapeutics Inc
26/11/2020	09:30	PR Newswire (Canada)	Crescita Therapeutics Announces Approval of Normal Course Issuer Bid	TSX:CTX	Crescita Therapeutics Inc
12/11/2020	09:30	PR Newswire (Canada)	Crescita Reports Third Quarter 2020 Results	TSX:CTX	Crescita Therapeutics Inc
05/11/2020	09:30	PR Newswire (Canada)	Crescita Announces Licensing Agreement for Pliaglis® in China	TSX:CTX	Crescita Therapeutics Inc
12/08/2020	08:30	PR Newswire (US)	Crescita Reports Second Quarter 2020 Results	TSX:CTX	Crescita Therapeutics Inc
28/07/2020	08:30	PR Newswire (US)	Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing Agreement	TSX:CTX	Crescita Therapeutics Inc
27/05/2020	08:30	PR Newswire (US)	Crescita Reports First Quarter 2020 Results	TSX:CTX	Crescita Therapeutics Inc
14/05/2020	09:30	PR Newswire (US)	Crescita Therapeutics Announces the Results of its Annual General Meeting of Shareholders	TSX:CTX	Crescita Therapeutics Inc
28/04/2020	18:58	PR Newswire (US)	Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19	TSX:CTX	Crescita Therapeutics Inc
24/03/2020	20:23	PR Newswire (US)	Crescita Therapeutics Announces Measures in Response to COVID-19 Virus	TSX:CTX	Crescita Therapeutics Inc
18/03/2020	08:30	PR Newswire (US)	Crescita Reports Q4 and Fiscal 2019 Results	TSX:CTX	Crescita Therapeutics Inc
10/03/2020	10:30	PR Newswire (Canada)	Pliaglis® finally available in Canada	TSX:CTX	Crescita Therapeutics Inc
10/03/2020	10:30	PR Newswire (Canada)	Pliaglis® enfin disponible au Canada	TSX:CTX	Crescita Therapeutics Inc
11/02/2020	09:30	PR Newswire (US)	Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patien...	TSX:CTX	Crescita Therapeutics Inc
24/01/2020	09:30	PR Newswire (US)	Crescita Awarded Cannabis Research License from Health Canada	TSX:CTX	Crescita Therapeutics Inc
22/01/2020	09:30	PR Newswire (US)	Crescita Secures Line of Credit with the Royal Bank of Canada Following Repayment in Full of Knight Therapeutics Loan	TSX:CTX	Crescita Therapeutics Inc
20/01/2020	09:30	PR Newswire (US)	Crescita Signs Exclusive Distribution Agreement with FILLMED	TSX:CTX	Crescita Therapeutics Inc
07/11/2019	09:30	PR Newswire (US)	Crescita Reports 2019 Third Quarter Results	TSX:CTX	Crescita Therapeutics Inc
05/11/2019	20:26	PR Newswire (US)	U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis®	TSX:CTX	Crescita Therapeutics Inc
28/10/2019	08:30	PR Newswire (US)	Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals	TSX:CTX	Crescita Therapeutics Inc
05/09/2019	08:00	PR Newswire (Canada)	Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City	TSX:CTX	Crescita Therapeutics Inc
08/08/2019	08:30	PR Newswire (US)	Crescita Reports Profitable 2019 Second Quarter Results	TSX:CTX	Crescita Therapeutics Inc
16/07/2019	08:30	PR Newswire (Canada)	United States Patent and Trademark Office Issues U.S. Patent Covering an Enhanced Formulation of Pliaglis®	TSX:CTX	Crescita Therapeutics Inc
11/07/2019	08:30	PR Newswire (US)	Crescita Therapeutics to Host Investor Webcast on July 24, 2019	TSX:CTX	Crescita Therapeutics Inc
04/07/2019	08:30	PR Newswire (Canada)	Crescita Therapeutics Inc. Receives 2nd Instalment of Up-Front Payment of €1.25 Million Following First Commercial Sale of ...	TSX:CTX	Crescita Therapeutics Inc
17/06/2019	21:17	PR Newswire (US)	Crescita Therapeutics Inc. Announces Intention to Make Normal Course Issuer Bid	TSX:CTX	Crescita Therapeutics Inc
30/05/2019	09:00	PR Newswire (US)	Crescita to Present at the 9th Annual LD Micro Invitational in Los Angeles, California	TSX:CTX	Crescita Therapeutics Inc
29/05/2019	09:00	PR Newswire (US)	Crescita Therapeutics Engages Bristol Capital to Provide Investor Relations and Communications Services	TSX:CTX	Crescita Therapeutics Inc
15/05/2019	09:31	PR Newswire (US)	Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders	TSX:CTX	Crescita Therapeutics Inc